# Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris

> **NCT07205107** · — · ACTIVE_NOT_RECRUITING · sponsor: **Bausch Health Americas, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** clindamycin phosphate, adapalene and benzoyl peroxide

## Key facts

- **NCT ID:** NCT07205107
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-02
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07205107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07205107, "Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07205107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*